Insight Molecular DiagnosticIMDX
13F holders, Q2 2025 (June 30)At the end of Q2 2025, 30 institutions reported holding Insight Molecular Diagnostic (IMDX) in their 13F filings, up 1 from Q1 2025. 5 opened new positions and 5 sold out. The largest holders were Broadwood Capital Inc. ($34.5M), AWM Investment Company, Inc. ($8.5M) and Pura Vida Investments, LLC ($2.9M). 3 famous investors held it, including Ken Griffin (0.0% of Citadel Advisors's portfolio), Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio) and Israel Englander (0.0% of Millennium Management's portfolio).
- Company
- Insight Molecular Diagnostic
- CUSIP
- 68235C206
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2025 → Q2 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 5 | $197K |
| Exits | 5 | $309K |
All 13F filers, Q1 2025 → Q2 2025: 315,700 shares bought and 1,096,265 shares sold, net −780,565 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 30 holders
| Broadwood Capital Inc. | 2.25% | No change | 11,410,100 | $34.5M |
| AWM Investment Company, Inc. | 0.96% | No change | 2,822,530 | $8.5M |
| Pura Vida Investments, LLC | 17.20% | Reduce -98.0% | 18,700 | $2.9M |
| Vanguard Group Inc. | 0.00% | Add +82.2% | 483,771 | $1.5M |
| Geode Capital Management, LLC | 0.00% | Reduce -0.8% | 157,580 | $476K |
| BlackRock, Inc. | 0.00% | Add +8.7% | 86,498 | $261K |
| Morgan Stanley | 0.00% | Add +0.8% | 62,208 | $188K |
| Defender Capital, LLC. | 0.03% | New | 32,928 | $99K |
| Northern Trust Corp. | 0.00% | Add +13.1% | 32,890 | $99K |
| Citadel Advisors | 0.00% | Reduce -36.6% | 30,907 | $93K |
| Renaissance Technologies | 0.00% | New | 26,100 | $79K |
| FNY Investment Advisers, LLC | 0.03% | Reduce -37.1% | 24,650 | $74K |
| State Street Corp. | 0.00% | No change | 19,554 | $59K |
| Millennium Management | 0.00% | Add +30.6% | 17,510 | $53K |
| UBS Group AG | 0.00% | Add +478.9% | 15,365 | $46K |
| Susquehanna International Group, LLP | 0.00% | Reduce -73.7% | 11,795 | $36K |
| EverSource Wealth Advisors, LLC | 0.00% | New | 5,000 | $15K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +283.9% | 4,468 | $13K |
| Osaic Holdings, Inc. | 0.00% | No change | 1,263 | $4K |
| Raymond James Financial Inc. | 0.00% | New | 1,189 | $4K |
| ORG Partners LLC | 0.00% | Add +144.4% | 1,100 | $3K |
| Bank of America Corp. | 0.00% | Add +29.3% | 570 | $2K |
| BNP Paribas Financial Markets | 0.00% | Add +14.4% | 238 | $719 |
| SBI Securities Co., Ltd. | 0.00% | No change | 185 | $559 |
| JPMorgan Chase & Co. | 0.00% | Reduce -8.3% | 154 | $465 |
| Piscataqua Savings Bank | 0.00% | No change | 25 | $75 |
| Albion Financial Group | 0.00% | No change | 7 | $22 |
| FMR LLC | 0.00% | New | 5 | $15 |
| Wells Fargo & Company | 0.00% | No change | 3 | $9 |
| Global Retirement Partners, LLC | 0.00% | — | 1 | $3 |
"% of holder's portfolio" is IMDX's weight in each manager's 13F, not the share of Insight Molecular Diagnostic the manager owns.